• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, INC. (CS-WOODRIDGE) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, INC. (CS-WOODRIDGE) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-23A
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Insufficiency, Valvular (1926); Unspecified Infection (1930); Pseudoaneurysm (2605); Fibrosis (3167)
Event Date 08/14/2014
Event Type  Injury  
Manufacturer Narrative
The results of the investigation are inconclusive since the device was not returned for analysis.A review of the device history record was not possible since the serial number was unavailable.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
According to an article "pseudo-aneurysm of mitral aortic intervalvular fibrosa after avr" (literature id 1601w2-060h, published in the japanese society for cardiovascular surgery 2015, vol.44, pp.334-337); a 23mm trifecta valve was implanted on (b)(6) 2014 secondary to aortic regurgitation.The valve functioned well by echo and the patient was discharged 21 days post-implant.The crp blood test result was 1.99mg/dl.During an outpatient follow-up on (b)(6) 2014, a diastolic murmur and cardiac t enlargement with chest - thoracic ratio of 50.2% were reported.A transthoracic echo (tte) revealed severe paravalvular leak and the diagnosis was an infection of the prosthesis requiring hospitalized.On (b)(6) 2014, a contrast ct confirmed mitral aortic intervalvular fibrosa (maif) and multiple pseudoaneurysms at the level of the left ventricular outflow tract (lvot) inferior to the aortic valve.On (b)(6) 2014, this trifecta valve was explanted and replaced with a 21mm non-sjm tissue valve.On (b)(6) 2014, the crp blood test result was 7.61mg/dl.Antibiotic therapy was initiated and cultures were negative 30 days post- procedure.The patient was discharged 50 days post-operatively with antibiotic therapy.A repeat tte confirmed good heart and valve function.Causal bacteria was not identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, INC. (CS-WOODRIDGE)
177 east county road b
st. paul MN 55117
Manufacturer (Section G)
ST. JUDE MEDICAL, INC. (CS-WOODRIDGE)
177 east county road b
st. paul MN 55117
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key5376470
MDR Text Key36257546
Report Number3007113487-2016-00008
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 01/15/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberTF-23A
Device Catalogue NumberTF-23A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/15/2016
Initial Date FDA Received01/19/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
Patient Weight50
-
-